摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Bis-(1,3-diphenyl-2-benzimidazolinyliden) | 35257-67-1

中文名称
——
中文别名
——
英文名称
Bis-(1,3-diphenyl-2-benzimidazolinyliden)
英文别名
1,3,1',3'-tetraphenyl-1,3,1',3'-tetrahydro-[2,2']bibenzoimidazolylidene;2-(1,3-Diphenylbenzimidazol-2-ylidene)-1,3-diphenylbenzimidazole
Bis-(1,3-diphenyl-2-benzimidazolinyliden)化学式
CAS
35257-67-1
化学式
C38H28N4
mdl
——
分子量
540.667
InChiKey
AXKNHHQKMVGSRX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    10
  • 重原子数:
    42
  • 可旋转键数:
    4
  • 环数:
    8.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    13
  • 氢给体数:
    0
  • 氢受体数:
    4

文献信息

  • [EN] ORGANIC COMPOUND, FIELD ELEMENT, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY APPARATUS, IMAGE INFORMATION-PROCESSING APPARATUS, LIGHTING APPARATUS, IMAGE-FORMING APPARATUS, AND EXPOSURE APPARATUS<br/>[FR] COMPOSÉ ORGANIQUE, ÉLÉMENT DE CHAMP, ÉLÉMENT ÉLECTROLUMINESCENT ORGANIQUE, APPAREIL D'AFFICHAGE, APPAREIL DE TRAITEMENT D'INFORMATIONS D'IMAGES, APPAREIL D'ÉCLAIRAGE, APPAREIL DE FORMATION D'IMAGES ET APPAREIL D'EXPOSITION
    申请人:CANON KK
    公开号:WO2015198579A1
    公开(公告)日:2015-12-30
    A bibenzo[d]imidazolidene compound inert to oxygen is provided. An aspect of the invention provides a 1,1',3,3'-tetraphenyl-2,2'-bibenzo[d]imidazolidene compound according to Claim 1, which is represented by general formula (1). In formula (1), R1 to R28 are each independently selected from a hydrogen atom and a substituent. The substituent is any of a halogen atom, an alkyl group containing 1 or more and 8 or less carbon atoms, and a substituted or unsubstituted aryl group. At least one of R1 to R28 is the substituent.
    提供一种对氧气惰性的双苯并[ d ]咪唑烷化合物。发明的一个方面提供了根据权利要求1提供的1,1',3,3'-四苯基-2,2'-双苯并[ d ]咪唑烷化合物,其由通式(1)表示。在式(1)中,R1至R28分别独立地选自氢原子和取代基。取代基是卤素原子、含有1个或多个碳原子和8个或更少碳原子的烷基基团,以及取代或未取代的芳基基团中的任何一种。R1至R28中至少有一个是取代基。
  • [EN] 2,2'-BIBENZO[D]IMIDAZOLIDENE COMPOUND HAVING CONDENSED RINGS AT THE 1-, 1'-, 3- AND 3'-POSITIONS, AND ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, IMAGE INFORMATION PROCESSING APPARATUS, LIGHTING DEVICE, IMAGE FORMING APPARATUS AND EXPOSURE UNIT, EACH CONTAINING THE SAME<br/>[FR] COMPOSÉ 2,2'-BIBENZO[D]IMIDAZOLIDÈNE AYANT DES CYCLES CONDENSÉS AUX POSITIONS 1, 1', 3 ET 3' ET ÉLÉMENT ÉLECTROLUMINESCENT ORGANIQUE, DISPOSITIF D'AFFICHAGE, APPAREIL DE TRAITEMENT D'INFORMATIONS IMAGES, DISPOSITIF D'ÉCLAIRAGE, APPAREIL DE FORMATION D'IMAGES ET UNITÉ D'EXPOSITION, CHACUN LE CONTENANT
    申请人:CANON KK
    公开号:WO2016084303A1
    公开(公告)日:2016-06-02
    A stable 2,2'-bibenzo[d]imidazolidene compound is provided. The 2,2'-bibenzo[d]imidazolidene compound is expressed by the following General Formula (1). In General Formula (1), Ar1 to Ar8 each represent a substituted or unsubstituted condensed ring. R1 to R8 each represent a hydrogen atom or a substituent.
    提供了一种稳定的2,2'-联苯[d]咪唑烷化合物。该2,2'-联苯[d]咪唑烷化合物由以下通式(1)表示。在通式(1)中,Ar1到Ar8分别表示取代或未取代的缩合环。R1到R8分别表示氢原子或取代基。
  • 2,2′-bibenzo[D]imidazolidene compound having heteromonocyclic groups at the 1-, 1′-, 3- and 3′- positions, and organic light-emitting element and display device containing the same
    申请人:CANON KABUSHIKI KAISHA
    公开号:US10193084B2
    公开(公告)日:2019-01-29
    A 2,2′-bibenzo[d]imidazolidene compound expressed by the following general formula (1). In general formula (1), Ar1 to Ar4 each represent a substituted or unsubstituted heteromonocyclic group. R1 to R8 each represent a hydrogen atom or a substituent.
    由以下通式(1)表示的 2,2′-联苯并[d]咪唑烷化合物。在通式(1)中,Ar1 至 Ar4 各自代表一个取代或未取代的杂环基团。R1 至 R8 各自代表氢原子或取代基。
  • 2,2′-bibenzo[D]imidazolidene compound having condensed rings at the 1-, 1′-, 3- and 3′-positions, and organic light-emitting element, display device, image information processing apparatus, lighting device, image forming apparatus and exposure unit, each containing the same
    申请人:CANON KABUSHIKI KAISHA
    公开号:US10403827B2
    公开(公告)日:2019-09-03
    A stable 2,2′-bibenzo[d]imidazolidene compound is provided. The 2,2′-bibenzo[d]imidazolidene compound is expressed by the following General Formula (1). In General Formula (1), Ar1 to Ar8 each represent a substituted or unsubstituted condensed ring. R1 to R8 each represent a hydrogen atom or a substituent.
    提供了一种稳定的 2,2′-联苯并[d]咪唑烷化合物。2,2′-联苯并[d]咪唑烷化合物由以下通式(1)表示。在通式(1)中,Ar1 至 Ar8 各自代表一个取代或未取代的缩合环。R1 至 R8 各代表一个氢原子或一个取代基。
  • ORGANIC COMPOUND, FIELD ELEMENT, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY APPARATUS, IMAGE INFORMATION-PROCESSING APPARATUS, LIGHTING APPARATUS, IMAGE-FORMING APPARATUS, AND EXPOSURE APPARATUS
    申请人:CANON KABUSHIKI KAISHA
    公开号:US20170155059A1
    公开(公告)日:2017-06-01
    A bibenzo[d]imidazolidene compound inert to oxygen is provided. A 1,1′,3,3′-tetraphenyl-2,2′-bibenzo[d]imidazolidene compound is represented by general formula (1). In formula (1), R 1 to R 28 are each independently selected from a hydrogen atom and a substituent. The substituent is any of a halogen atom, an alkyl group containing 1 or more and 8 or less carbon atoms, and a substituted or unsubstituted aryl group. At least one of R 1 to R 28 is the substituent.
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)